Hanson Wade

Oncology
8th Tumor Models San Francisco Summit 2024
Partner Content

8th Tumor Models San Francisco Summit 2024

Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the fie

R&D
5th RNAi-Based Therapeutics Summit
Partner Content

5th RNAi-Based Therapeutics Summit

Despite exciting advancements and new investments into the field, the development of new RNAi therapeutics is plagued by difficulties with extra-hepatic delivery and scale-up of manufacturi

R&D
7th Obesity & NASH Drug Development Summit
Partner Content

7th Obesity & NASH Drug Development Summit

Reuniting metabolic experts to enable the assessment of the competitive landscape, the 7th Obesity & NASH Drug Development Summit is your exclusive industry meeting to:

R&D
Antifibrotic Drug Development Summit
Partner Content

Antifibrotic Drug Development Summit

As fibrosis stakeholders invest in bolstering their early pipeline to limit early candidate drop off, the 7th Antifibrotic Drug Development (AFDD) Summit explores actionable strategies to t